878110P
C16-02:0 PC
Manufacturer: Sigma Aldrich
CAS Number: 74389-68-7
Synonym(S): 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 5 MG | 878110P-5-MG | In Stock | ₹ 18,510.75 |
| 25 MG | 878110P-25-MG | In Stock | ₹ 65,177.33 |
878110P - 5 MG
In Stock
Quantity
1
Base Price: ₹ 18,510.75
GST (18%): ₹ 3,331.935
Total Price: ₹ 21,842.685
form
powder
packaging
pkg of 1 × 25 mg (878110P-25mg)pkg of 1 × 5 mg (878110P-5mg)
manufacturer/tradename
Avanti Polar Lipids 878110P
lipid type
phosphoglyceridesbioactive lipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(C)=O)COCCCCCCCCCCCCCCCC)=O
InChI
1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1
InChI key
HVAUUPRFYPCOCA-AREMUKBSSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Enzo Life Sciences 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine (5mg). CAS: 74389-68-7 | Enzo Life Sciences | ₹ 8,265.10 | |
 | C16-02:0 PC | Sigma Aldrich | ₹ 48,964.05 | |
 | 74389-68-7 | Paf (c16) | A2B Chem | ₹ 2,823.48 - ₹ 19,849.92 |
Related Products
Description
- General description: C16-02:0 PC, also referred as 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16 PAF) (acetyl PAF), is a platelet-activating factor (PAF). Acetyl PAF is a natural PAF with ether-linked hexadecyl chain at the sn-1 position and an acetyl group at the sn-2 position.[1]
- Application: C16-02:0 PC or 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine may be used as a substrate in enzymatic lipoprotein-associated phospholipase A2 (Lp-PLA2) activity assay.[2] It may also be used to study its physicochemical properties and its interaction with peptides derived from the C-terminal domains of human apolipoprotein E.[1]
- Biochem/physiol Actions: C16-02:0 PC, a platelet-activating factor and a lipid mediator is involved in various inflammatory diseases.[3] It facilitates initiation and progression of atherosclerosis. PAF acts as a potential biomarker for coronary artery diseases. It exhibits its activity by binding to a specific PAF receptor, which belongs to the seven transmembrane-spanning G-protein-linked receptors family. PAF on hydrolysis by platelet-activating factor-acetyl hydrolase produces LysoPAF (1-O-alkyl-2-hydroxy-sn-glycero-3-phosphocholine).[2]
- Packaging: 5 mL Clear Glass Sealed Ampule (878110P-25mg)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
form: powder
packaging: pkg of 1 × 25 mg (878110P-25mg)pkg of 1 × 5 mg (878110P-5mg)
manufacturer/tradename: Avanti Polar Lipids 878110P
lipid type: phosphoglyceridesbioactive lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(C)=O)COCCCCCCCCCCCCCCCC)=O
InChI: 1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1
InChI key: HVAUUPRFYPCOCA-AREMUKBSSA-N
form:
powder
packaging:
pkg of 1 × 25 mg (878110P-25mg)pkg of 1 × 5 mg (878110P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 878110P
lipid type:
phosphoglyceridesbioactive lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(C)=O)COCCCCCCCCCCCCCCCC)=O
InChI:
1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1
InChI key:
HVAUUPRFYPCOCA-AREMUKBSSA-N
form: liquid
packaging: pkg of 1 × 1 mL (878112C-5mg)
manufacturer/tradename: Avanti Polar Lipids 878112C
lipid type: phosphoglyceridesbioactive lipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)COCCCCCCCCCCCCCCCC)=O
InChI: __
InChI key: __
form:
liquid
packaging:
pkg of 1 × 1 mL (878112C-5mg)
manufacturer/tradename:
Avanti Polar Lipids 878112C
lipid type:
phosphoglyceridesbioactive lipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)COCCCCCCCCCCCCCCCC)=O
InChI:
__
InChI key:
__
form: powder
packaging: pkg of 1 × 5 mg (878112P-5mg)
manufacturer/tradename: Avanti Polar Lipids 878112P
lipid type: bioactive lipidsphosphoglycerides
shipped in: dry ice
storage temp.: −20°C
SMILES string: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)COCCCCCCCCCCCCCCCC)=O
InChI: __
InChI key: __
form:
powder
packaging:
pkg of 1 × 5 mg (878112P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 878112P
lipid type:
bioactive lipidsphosphoglycerides
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCC/C=C\CCCCCCCC)=O)COCCCCCCCCCCCCCCCC)=O
InChI:
__
InChI key:
__
form: liquid
packaging: pkg of 1 × 1 mL (878113C-5mg)
manufacturer/tradename: Avanti Polar Lipids 878113C
lipid type: bioactive lipidsphosphoglycerides
shipped in: dry ice
storage temp.: −20°C
SMILES string: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COCCCCCCCCCCCCCCCC)=O
InChI: 1S/C44H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20,22,24-25,29,31,43H,6-13,15,17-19,21,23,26-28,30,32-42H2,1-5H3/b16-14-,22-20-,25-24-,31-29-/t43-/m1/s1
InChI key: DUUSFCFZBREELS-WWBBCYQPSA-N
form:
liquid
packaging:
pkg of 1 × 1 mL (878113C-5mg)
manufacturer/tradename:
Avanti Polar Lipids 878113C
lipid type:
bioactive lipidsphosphoglycerides
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COCCCCCCCCCCCCCCCC)=O
InChI:
1S/C44H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20,22,24-25,29,31,43H,6-13,15,17-19,21,23,26-28,30,32-42H2,1-5H3/b16-14-,22-20-,25-24-,31-29-/t43-/m1/s1
InChI key:
DUUSFCFZBREELS-WWBBCYQPSA-N